0001851194EX-FILING FEESCommon Stock, par value $0.0001 per share 0001851194 2024-11-07 2024-11-07 0001851194 1 2024-11-07 2024-11-07 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Tables
Form
S-3
(Form Type)
Ventyx Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
 
                         
    
Security 
Type 
 
Security
Class Title
 
Fee
Calculation
or Carry
Forward
Rule
 
Amount
Registered
 
Proposed
Maximum
Offering
Price Per
Unit
 
Maximum
Aggregate
Offering Price
 
Fee Rate
 
Amount of
Registration
Fee
 
Carry
Forward
Form
Type
 
Carry
Forward
File
Number
 
Carry
Forward
Initial
effective
date
 
Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
be Carried
Forward
 
Newly Registered Securities
                         
Fees to Be Paid
  Equity  
Common Stock
, 
par value 
$0.0001 per share 
  457(c)  
7,060,100
(1) 
  $2.15 (2)    $15,179,215   0.0001531   $2,323.94    —      —      —    
                         
Fees Previously Paid
  —    —    —    —    —    —    —    —    —    —    —   
 
Carry Forward Securities
                         
Carry Forward Securities
  —    —    —    —    —    —    —    —    —    —    —   
                   
   
Total Offering Amounts
    $
15,179,215
    $2,323.94          
                   
   
Total Fees Previously Paid
                 
                   
   
Total Fee Offsets
                 
                   
   
Net Fee Due
              $2,323.94                
 
(1)
Represents the shares of common stock, $0.0001 par value per share of Ventyx Biosciences, Inc. (the “Company”) issuable upon conversion of the Series A Preferred Stock of the Company, which the selling stockholder may at any time choose to convert and offer for resale pursuant to the prospectus to which this exhibit is attached. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the registrant is also registering an indeterminate number of additional shares of common stock issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction.
 
(2)
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) of the Securities Act, and based upon the average of the high and low prices for a share of the registrant’s common stock as reported on the Nasdaq Global Select Market on November 4, 2024 (such date being within five business days of the date that this registration statement was filed with the U.S. Securities and Exchange Commission).